Literature DB >> 24008558

Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium.

Dolores López-Terrada1, Rita Alaggio2, Maria T de Dávila3, Piotr Czauderna4, Eiso Hiyama5, Howard Katzenstein6, Ivo Leuschner7, Marcio Malogolowkin8, Rebecka Meyers9, Sarangarajan Ranganathan10, Yukichi Tanaka11, Gail Tomlinson12, Monique Fabrè13, Arthur Zimmermann14, Milton J Finegold1.   

Abstract

Liver tumors are rare in children, and their diagnoses may be challenging particularly because of the lack of a current consensus classification system. Systematic central histopathological review of these tumors performed as part of the pediatric collaborative therapeutic protocols has allowed the identification of histologic subtypes with distinct clinical associations. As a result, histopathology has been incorporated within the Children's Oncology Group (COG) protocols, and only in the United States, as a risk-stratification parameter and for patient management. Therefore, the COG Liver Tumor Committee sponsored an International Pathology Symposium in March 2011 to discuss the histopathology and classification of pediatric liver tumors, and hepatoblastoma in particular, and work towards an International Pediatric Liver Tumors Consensus Classification that would be required for international collaborative projects. Twenty-two pathologists and experts in pediatric liver tumors, including those serving as central reviewers for the COG, European Société Internationale d'Oncologie Pédiatrique, Gesellschaft für Pädiatrische Onkologie und Hämatologie, and Japanese Study Group for Pediatric Liver Tumors protocols, as well as pediatric oncologists and surgeons specialized in this field, reviewed more than 50 pediatric liver tumor cases and discussed classic and newly reported entities, as well as criteria for their classification. This symposium represented the first collaborative step to develop a classification that may lead to a common treatment-stratification system incorporating tumor histopathology. A standardized, clinically meaningful classification will also be necessary to allow the integration of new biological parameters and to move towards clinical algorithms based on patient characteristics and tumor genetics, which should improve future patient management and outcome.

Entities:  

Mesh:

Year:  2013        PMID: 24008558     DOI: 10.1038/modpathol.2013.80

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  70 in total

1.  Hepatoblastoma in a Young Adult: a Rare Case Report and Review of the Literature.

Authors:  Jeewan Ram Vishnoi; Ajai Sasidhar; Sanjeev Misra; Puneet Pareek; Sudeep Khera; Sushil Kumar; Ankit Jain
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.

Authors:  Xianghai Ren; Haibo Li; Mei Diao; Hang Xu; Long Li
Journal:  Int J Clin Oncol       Date:  2019-11-07       Impact factor: 3.402

3.  Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Authors:  Sarah A Comerford; Elizabeth A Hinnant; Yidong Chen; Hima Bansal; Shawn Klapproth; Dinesh Rakheja; Milton J Finegold; Dolores Lopez-Terrada; Kathryn A O'Donnell; Gail E Tomlinson; Robert E Hammer
Journal:  JCI Insight       Date:  2016-10-06

4.  Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children's Oncology Group.

Authors:  Amanda E Janitz; Gurumurthy Ramachandran; Gail E Tomlinson; Mark Krailo; Michaela Richardson; Logan Spector
Journal:  J Expo Sci Environ Epidemiol       Date:  2017-03-08       Impact factor: 5.563

Review 5.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

6.  Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee.

Authors:  Christopher B Weldon; Arin L Madenci; Gregory M Tiao; Stephen P Dunn; Max R Langham; Eugene D McGahren; Sarangarajan Ranganathan; Dolores H López-Terrada; Milton J Finegold; Marcio H Malogolowkin; Jin Piao; Li Huang; Mark D Krailo; Rebecka L Meyers; Howard M Katzenstein
Journal:  J Pediatr Surg       Date:  2019-05-11       Impact factor: 2.545

7.  Current therapeutic strategies for childhood hepatic malignant tumors.

Authors:  Eiso Hiyama
Journal:  Int J Clin Oncol       Date:  2013-09-21       Impact factor: 3.402

8.  Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma.

Authors:  Laura Molina; Danielle Bell; Junyan Tao; Morgan Preziosi; Tirthadipa Pradhan-Sundd; Sucha Singh; Minakshi Poddar; Jianhua Luo; Sarangarajan Ranganathan; Maria Chikina; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2018-06-18       Impact factor: 4.307

9.  The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.

Authors:  Piotr Czauderna; Beate Haeberle; Eiso Hiyama; Arun Rangaswami; Mark Krailo; Rudolf Maibach; Eugenia Rinaldi; Yurong Feng; Daniel Aronson; Marcio Malogolowkin; Kenichi Yoshimura; Ivo Leuschner; Dolores Lopez-Terrada; Tomoro Hishiki; Giorgio Perilongo; Dietrich von Schweinitz; Irene Schmid; Kenichiro Watanabe; Marisa Derosa; Rebecka Meyers
Journal:  Eur J Cancer       Date:  2015-12-01       Impact factor: 9.162

Review 10.  Rare Tumors in Children: Progress Through Collaboration.

Authors:  Alberto S Pappo; Wayne L Furman; Kris A Schultz; Andrea Ferrari; Lee Helman; Mark D Krailo
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.